Redx Pharma (LSE:REDX) Price-to-Operating-Cash-Flow : (As of Jun. 13, 2024)

View and export this data going back to 2015. Start your Free Trial

What is Redx Pharma Price-to-Operating-Cash-Flow?

As of today (2024-06-13), Redx Pharma's share price is £0.15. Redx Pharma's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 was £-0.10. Hence, Redx Pharma's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Redx Pharma's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 12 years, Redx Pharma's highest Price-to-Operating-Cash-Flow Ratio was 505.00. The lowest was 0.32. And the median was 126.80.

LSE:REDX's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 25.59
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Redx Pharma's Cash Flow from Operations per share for the six months ended in Sep. 2023 was £-0.05. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 was £-0.10.

During the past 12 years, Redx Pharma's highest 3-Year average Operating Cash Flow per Share Growth Rate was 38.60% per year. The lowest was -74.80% per year. And the median was -6.40% per year.

Redx Pharma Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Redx Pharma's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Redx Pharma Price-to-Operating-Cash-Flow Chart

Redx Pharma Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

282.36

Redx Pharma Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Redx Pharma's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Redx Pharma's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Redx Pharma's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Redx Pharma's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Redx Pharma's Price-to-Operating-Cash-Flow falls into.

Redx Pharma Price-to-Operating-Cash-Flow Calculation

Redx Pharma's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.15	/	-0.104
	=

Redx Pharma's Share Price of today is £0.15.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Redx Pharma's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 was £-0.10.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Redx Pharma Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Redx Pharma's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Redx Pharma (LSE:REDX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Redx Pharma PLC (LSE:REDX) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

Block 33, Mereside, Alderley Park, Macclesfield, GBR, SK10 4TG

Website

https://www.redxpharma.com

Redx Pharma PLC is a United Kingdom-based biotechnology company focused on the development of novel precision medicines that have the potential to transform treatment in oncology and fibrotic diseases. Its product pipeline under development includes Porcupine Inhibitor, ROCK2 Selective Inhibitor, GI-targeted ROCK inhibitor, Pan-RAF Inhibitor, and others. The firm operates geographically in UK and Ireland. Revenue is generated from; Scientific programmes and research collaboration, Research collaboration and Research and preclinical development services. Redx is a clinical-stage biotechnology company focused on the discovery & development of novel, small-molecule, targeted medicines for the treatment of cancer and fibrotic disease and the emerging area of cancer-associated fibrosis.

Redx Pharma (LSE:REDX) Headlines

No Headlines